Wednesday, May 8, 2024
News

CDL Kasauli clears over 21 lakh mRNA COVID-19 vaccine doses: Sources

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

By Shalini Bhardwaj

New Delhi | May 13, 2022 5:54:07 PM IST
The Central Drugs Laboratory (CDL), Kasauli has cleared more than 21 lakh mRNA COVID-19 vaccine doses for stockpiling, the sources told ANI.

India has started stockpiling its first mRNA Covid 19 vaccine. This vaccine is manufactured by Pune-based Gennova Biopharmaceuticals Ltd.

The CDL Kasauli under the Health Ministry is responsible for checking the safety and efficacy of the vaccine, the sources said.

The company hasn't submitted the data of phase 3 trials to the Central Drug Standard Control Organisation (CDSCO) yet, but interim data for the approval has been submitted by the company in the month of March.

The company said that it has filed its phase 2 data with CDSCO in the month of January this year.

Gennova's mRNA vaccine is an Omicron-specific vaccine and has already tweaked its mRNA platform that will target Omicron.

ANI went further and generated some more queries to the company about the latest updates on data submitted to CDSCO but the company refused to answer. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'Why are people in Odisha poor despite s...
BJP tears into Sam Pitroda, dubs his 'Ea...
Madhya Pradesh: Bus carrying EVMs, polli...
Sena (UBT) mounthpiece questions Cong le...
Setback for AAP in Punjab: Former Amrits...
AAP's Saurabh Bharadwaj questions Centre...
More...    
 
 Top Stories
STL well-positioned to deliver stro... 
The Convergence Foundation and Indi... 
Remedium Lifecare Limited Sparks In... 
MDI Gurgaon Student Arun Mehta Achi... 
Veg thali in India got dearer in Ap... 
Stock markets witness high volatili... 
How to Achieve High-Quality Product... 
Infosys to Accelerate Yunex Traffic...